Overview

Eitr Biologics develops next-generation immunotherapies for infectious diseases that threaten public health, with a focus on making lifesaving treatments globally accessible. Its approach centers on immunotherapies that boost or modulate the immune response to pathogens and on collaboration to validate and scale solutions for broad deployment. The company differentiates itself by prioritizing global accessibility and public-health impact through a worldwide network of academic and government partners, rather than relying on a single platform. Its goal is to provide lifesaving immunotherapies and expand worldwide access to these treatments to address current and emerging public health threats.

Significant Headcount Growth